다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) (APCVZ)
Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) (APCVZ) 뉴스

APCVZ

Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM) (APCVZ)

Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:APCVZ

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2011/03/08	04:58	Business Wire	Fresenius Kabi Pharmaceuticals Holding, Inc. Files Form 25 to Delist & Deregister Contingent Value Rights for APP Pharmaceuti...	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2011/02/23	20:04	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2011/02/23	20:04	Edgar (US Regulatory)	Annual Report (10-K)	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2011/02/23	15:01	Business Wire	Fresenius Kabi Pharmaceuticals Holding, Inc. Files Form 10-K for APP Pharmaceuticals, Inc. (APP)	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2011/01/26	22:00	Business Wire	APP Pharmaceuticals Announces Agreement with Teva Pharmaceuticals to Manufacture and Market Gemcitabine HCI for Injection	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/11/30	15:01	Business Wire	APP Pharmaceuticals Announces Approval and Launch of Topotecan for Injection	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/11/06	04:39	Business Wire	APP Pharmaceuticals to Launch Drug Hotline	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/11/02	19:04	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/11/02	09:16	Business Wire	Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/10/30	07:53	Business Wire	APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/08/03	08:15	Business Wire	Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/08/03	06:16	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/07/28	02:14	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/07/06	14:01	Business Wire	APP Pharmaceuticals Announces Marketing Clearance of Preservative-Free Heparin Lock Flush Solution, USP	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/06/30	03:44	Edgar (US Regulatory)	Annual Report of Employee Stock Plans (11-K)	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/06/29	14:01	Business Wire	APP Pharmaceuticals to Market Anastrozole Tablets in the U.S.	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/06/22	14:01	Business Wire	APP Pharmaceuticals Announces Approval of Ganciclovir for Injection, USP	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/06/21	14:01	Business Wire	APP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USP	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/06/11	14:01	Business Wire	APP Pharmaceuticals to Market Oxaliplatin Injection (Liquid) in the U.S.	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/06/08	14:01	Business Wire	APP Pharmaceuticals Receives Approval for Lyophilized Oxaliplatin for Injection	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/05/10	19:07	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/05/04	19:04	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/05/04	07:41	Business Wire	Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-Q	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/04/02	00:39	Business Wire	Fresenius Kabi Enters Into Licensing and Settlement Agreements with sanofi-aventis	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/04/01	06:27	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/03/25	22:15	GlobeNewswire Inc.	Emerging Stock Report Initiates Independent Research Coverage on Fresenius Kabi Pharmaceuticals Holding, Inc.	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/03/23	14:01	Business Wire	APP Pharmaceuticals Receives Approval for Indomethacin for Injection	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/02/26	05:43	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/02/24	20:03	Edgar (US Regulatory)	Annual Report (10-K)	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)
2010/02/24	10:08	Business Wire	Fresenius Kabi Pharmaceuticals Holding, Inc. Announces Filing of Form 10-K	NASDAQ:APCVZ	Fresenius Kabi Pharmaceuticals Holding - Contingent Value Rights (MM)

검색 관련기사 보기:NASDAQ:APCVZ

1 2 3 다음 >>

Verizon Communications

Deutsche Telekom (QX)

Financial Select Sector

Energy Select Sector SPDR

JP Morgan Chase

US Dollar vs Sterling

Health Care Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관